Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online:265
  • Home
  • Print this page
  • Email this page
Year : 2013  |  Volume : 27  |  Issue : 3  |  Page : 182-184

Role of Duloxetine in management of cervical or lumbosacral neuralgia of unknown etiology: A preliminary study

1 Pain Specialist, Doon Nursing Home, Dehradun, Uttarakhand, India
2 Department of Anesthesia, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India

Correspondence Address:
Sanjay Agrawal
Department of Anesthesia, Himalayan Institute of Medical Sciences, Swami Ram Nagar, Dehradun - 248 140, Uttarakhand
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0970-5333.124605

Rights and Permissions

Background: Duloxetine is a selective serotonin reuptake inhibitor (SSRI) used for treatment of neuropathic pain associated with diabetic neuropathy and fibromyalgia. Use of duloxetine for idiopathic neuropathic pain is not known. We present our experience for treatment of such painful conditions. Materials and Methods: Twenty patients, either sex, aged 30-65 years presenting for cervical and lumbosacral pain were administered duloxetine 40 mg/day in two divided doses. They were followed for a total period of 20 weeks and pain was assessed periodically using Numerical scale and Facies scale. Results: Fifteen patients showed complete resolution of pain. No major side effects were seen. No patient showed less than 50% resolution of pain. Conclusion: Duloxetine 40 mg/day is effective for control of painful neuropathic condition in our Indian setup.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded445    
    Comments [Add]    

Recommend this journal